<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Affimed on 生物经济</title><link>https://cn.bioecon.ru/companies/affimed/</link><description>Recent content in Affimed on 生物经济</description><generator>Hugo</generator><language>zh-CN</language><lastBuildDate>Mon, 29 Jun 2026 21:20:06 +0700</lastBuildDate><atom:link href="https://cn.bioecon.ru/companies/affimed/index.xml" rel="self" type="application/rss+xml"/><item><title>NK 细胞与 CAR-NK 疗法</title><link>https://cn.bioecon.ru/technology/nk-cell-car-nk-therapy/</link><pubDate>Fri, 19 Jun 2026 00:00:00 +0000</pubDate><guid>https://cn.bioecon.ru/technology/nk-cell-car-nk-therapy/</guid><description>CAR-NK 与 NK 细胞疗法 — 对抗实体瘤和血液肿瘤的同种异体、现货型效应细胞，具有低毒性（极少 CRS，无 GVHD）；iPSC-NK 是可扩展的平台。</description></item></channel></rss>